Oura, a leading health intelligence platform and maker of the world’s smallest smart ring, announced today that it is postponing its previously announced initial public offering on Nasdaq, despite strong demand, due to uncertainty in the IPO market.
Oura is profitable, growing meaningfully, and the business has further strengthened since beginning the IPO process. Consumer response to Oura Ring 5 has been exceptionally strong, bringing the number of paid members to 5.7 million. For the fiscal year 2026, revenue is expected to grow 90 percent year over year.
“Our mission is to empower people to live healthier, longer, and an IPO is just one step in our journey,” said Tom Hale, CEO of ŌURA. “We aim to deliver an extraordinary IPO for our employees and investors and we have the luxury of choosing our moment. In the meantime, we will execute against the opportunities ahead.”
A Registration Statement on Form S-1 relating to the proposed offering of securities was filed with the U.S. Securities and Exchange Commission (the “SEC”) but has not yet been declared effective. Such securities may not be sold nor may offers to buy such securities be accepted prior to the time the registration statement is declared effective.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.
About Oura
ŌURA is a health intelligence platform designed to transform how people understand and manage their health in everyday life. Oura’s platform is anchored by Oura Ring, the world’s leading smart ring that empowers you to live healthier, longer. Oura supports millions of members worldwide across sleep, activity, stress, readiness, women’s health, metabolic health, and heart health. Oura Ring is purpose-built to leverage the finger’s unique physiological advantages for photoplethysmography (PPG) measurement, producing a stronger signal than wrist-based wearables. Scientifically validated against medical gold standards, the lightweight Oura Ring tracks 50+ health metrics continuously, empowering both individuals and thousands of research teams, healthcare providers, sports teams, and organizations. Trusted by an ecosystem of more than 1,200 partners, Oura is advancing the future of preventative health with privacy and security at the forefront.
Founded in Finland in 2013, Oura is headquartered in San Francisco with E.U. headquarters in Oulu, Finland.
Oura Ring is not a medical device and is not intended to diagnose, treat, cure, monitor, or prevent medical conditions or illnesses.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260929159734/en/
Media gallery
